mRNA treatment produces sustained expression of enzymatically active human ADAMTS13 in mice
出版年份 2018 全文链接
标题
mRNA treatment produces sustained expression of enzymatically active human ADAMTS13 in mice
作者
关键词
-
出版物
Scientific Reports
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-05-14
DOI
10.1038/s41598-018-26298-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA
- (2018) Kirtika H. Asrani et al. RNA Biology
- Leveraging Rational Protein Engineering to Improve mRNA Therapeutics
- (2018) Jeremiah D. Farelli et al. Nucleic Acid Therapeutics
- cmRNA/lipoplex encapsulation in PLGA microspheres enables transfection via calcium phosphate cement (CPC)/PLGA composites
- (2017) Maximilian Utzinger et al. JOURNAL OF CONTROLLED RELEASE
- Systemic delivery of factor IX messenger RNA for protein replacement therapy
- (2017) Suvasini Ramaswamy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
- (2017) Norbert Pardi et al. Nature Communications
- Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNA
- (2017) Eva Schrom et al. Molecular Therapy-Nucleic Acids
- Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study
- (2016) Ygal Benhamou et al. AMERICAN JOURNAL OF HEMATOLOGY
- Correlation between ADAMTS13 activity and neurological impairment in acute thrombotic microangiopathy patients
- (2016) Giulia Berti de Marinis et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
- (2016) Flora Peyvandi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models
- (2015) B. Pickens et al. BLOOD
- N 1 -methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice
- (2015) Oliwia Andries et al. JOURNAL OF CONTROLLED RELEASE
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
- (2015) Norbert Pardi et al. JOURNAL OF CONTROLLED RELEASE
- The splenic autoimmune response to ADAMTS13 in thrombotic thrombocytopenic purpura contains recurrent antigen-binding CDR3 motifs
- (2014) M. Schaller et al. BLOOD
- Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura
- (2013) Marshall A. Mazepa et al. BRITISH JOURNAL OF HAEMATOLOGY
- Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura
- (2013) S. Ferrari et al. HAEMATOLOGICA
- Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura
- (2013) L. A. Lotta et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction
- (2013) Lior Zangi et al. NATURE BIOTECHNOLOGY
- A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13
- (2012) A. Schiviz et al. BLOOD
- Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura
- (2012) C. Jian et al. BLOOD
- Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice
- (2012) S. F. De Meyer et al. BLOOD
- Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura
- (2012) John Chapin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura
- (2011) Spero R. Cataland et al. AMERICAN JOURNAL OF HEMATOLOGY
- N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice
- (2011) Junmei Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies
- (2011) B. PLAIMAUER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- ADAMTS13 Bound to Endothelial Cells Exhibits Enhanced Cleavage of von Willebrand Factor
- (2009) Anthony N. Vomund et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Disintegrin-like and Metalloprotease (Reprolysin-type) with Thrombospondin Type 1 Motif (ADAMTS) Superfamily: Functions and Mechanisms
- (2009) Suneel S. Apte JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started